Amylyx Pharmaceuticals, Inc. (AMLX) vs Aveanna Healthcare Holdings Inc. (AVAH)
A side-by-side comparison of Amylyx Pharmaceuticals, Inc. and Aveanna Healthcare Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMLX
Amylyx Pharmaceuticals, Inc.
$28.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
AVAH
Aveanna Healthcare Holdings Inc.
$12.22HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AMLX vs AVAH
growth of $100 · dividends reinvested · last 5yAMLX +53.7% (+9.0%/yr)AVAH +75.7% (+11.9%/yr)AVAH compounded faster over this window
AMLX AVAH
AMLX vs AVAH: by the numbers
- •AMLX is the larger company ($3.12B vs $2.66B market cap).
- •AVAH is profitable (10.56% net margin) while AMLX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AMLX | AVAH |
|---|---|---|
| P/E ratio | N/A | 9.67 |
| Forward P/E | N/A | 14.84 |
| P/S ratio | N/A | 1.02 |
| P/B ratio | 13.04 | 9.26 |
| EV / EBITDA | N/A | 13.13 |
| FCF yield | N/A | 5.95% |
Profitability
| Metric | AMLX | AVAH |
|---|---|---|
| Gross margin | 0.00% | 31.95% |
| Operating margin | 0.00% | 11.12% |
| Net margin | 0.00% | 10.56% |
| ROE | -63.59% | 95.64% |
| ROIC | -66.60% | 15.45% |
Growth (annualized)
| Metric | AMLX | AVAH |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.65% |
| FCF CAGR (5Y) | N/A | 58.99% |
| Total return CAGR (5Y) | N/A | 9.75% |
Frequently asked
- Is AMLX or AVAH more profitable?
- AVAH runs the higher net margin — AMLX at 0.00% versus AVAH at 10.56%.
Go deeper
Dig into the metrics
Aveanna Healthcare P/E ratioAmylyx Pharmaceuticals ROEAveanna Healthcare ROEAmylyx Pharmaceuticals operating marginAveanna Healthcare operating marginAmylyx Pharmaceuticals revenue growthAveanna Healthcare revenue growthAmylyx Pharmaceuticals free cash flowAveanna Healthcare free cash flow
Amylyx Pharmaceuticals & Aveanna Healthcare appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.